Autoimmunity Against Surfactant Protein B is Associated with Pneumonitis During Checkpoint Blockade

Immune checkpoint inhibitor-related pneumonitis is a serious autoimmune event affecting up to 20% of patients with non-small cell lung cancer, yet the factors underpinning its development in some patients and not others are poorly understood.